Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,970 public trials 1,254 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Completed

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

NCT00052507

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +11 more
Locations
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada
View Trial Details
Completed

Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients

NCT01030042

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • A.O. Ospedale Umberto I - Università - Località Torretta Ancona, Italy
  • Ospedale Profili Fabriano, AN, Italy
  • Usl 11 Ospedale Murri Fermo, AP, Italy
  • Ospedali Riuniti, Largo Barozzi, 1 Bergamo, Italy
View all 32 locations
View Trial Details
Completed

First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer

NCT01853813

Conditions
Colonic Diseases, Colorectal Cancer Stage II, Colorectal Neoplasms, +9 more
Locations
  • A.O. Universitaria - Ospedali Riuniti Ancona, Italy
  • A.O. Ospedale G.Rummo Benevento, Italy
  • A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy
  • Istituto Ospedaliero Fondazione Poliambulanza Brescia, Italy
View all 13 locations
View Trial Details
Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions
Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Columbia University - Herbert Irving Cancer Center New York, United States
  • New York University Cancer Institute New York, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

NCT01478594

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Banner MD Anderson Cancer Research Center Gilbert, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • University of California San Diego-Morris Cancer Center La Jolla, California, United States
View all 73 locations
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

NCT00890305

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • The Cancer Center of Huntsville, PC Huntsville, Alabama, United States
  • University of South Florida Tampa, Florida, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Signal Point Clinical Research Center Middletown, Ohio, United States
View all 31 locations
View Trial Details
Completed

Adherence to Minimally Invasive Testing

NCT02251782

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Kaiser Permanente Center for Health Research Portland, Oregon, United States
  • Geisinger Clinic Danville, Pennsylvania, United States
View Trial Details

Related conditions